An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
Katarina RaslovaMetabolic Center Ltd and Slovak Medical University, Bratislava, Slovak RepublicAbstract: Basal insulin analogs are used to minimize unpredictable processes of NPH insulin. Modification of the human insulin molecule results in a slower distribution to peripheral target tissues, a long...
Main Author: | Katarina Raslova |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-05-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/an-update-on-the-treatment-of-type-1-and-type-2-diabetes-mellitus-focu-a4489 |
Similar Items
-
Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
by: Jason R. Young, et al.
Published: (2010-01-01) -
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020-05-01) -
Insulin detemir in the treatment of type 1 and type 2 diabetes
by: Jean-Christophe Philips, et al.
Published: (2006-09-01) -
Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
by: Gregory E Peterson
Published: (2009-05-01) -
Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
by: Kitty Poon, et al.
Published: (2010-10-01)